Category: Fertility, Low AMH, Ovulation Induction vs. ICSI Care
Can you do IVF with low AMH? What to do when ovarian-reserve hormone is low
ไทย · English
· ☕ Buy me a coffee
AMH
from granulosa cells marks egg quantity, not per-egg quality — so you can do IVF with a low value, and it is not a sterility diagnosis.
What changes is eggs per cycle and the time box, not eligibility.
At AMH ~0.95 ng/mL and age 36, a 2–3 cycle OI/IUI trial is still reasonable if tubes are open.
Red flags during fertility treatment — seek care or emergency help now
Go to a hospital now for rapid abdominal swelling, shortness of breath, sudden one-sided pelvic pain, or heavy bleeding after stimulation or egg retrieval — low AMH does not zero out emergency risk.
- Rapid abdominal swelling, shortness of breath, relentless vomiting, or sudden weight gain after ovarian stimulation (possible OHSS)
- Sudden severe one-sided lower abdominal pain — possible ovarian torsion
- Abdominal pain with abnormal bleeding after a missed period or embryo transfer, plus marked dizziness (possible ectopic pregnancy)
- Heavy bleeding, fever after egg retrieval, chest pain, or calf swelling after procedures
Can you do IVF with low AMH?
Yes. There is no universal cutoff that bars
IVF
because AMH is low.
Per the
ASRM 2020 committee opinion,
AMH/AFC predict egg yield under stimulation, not “you cannot conceive,” and should not be used alone to refuse treatment.
Low AMH usually means fewer eggs per cycle — you may need more cycles or a protocol change — not a ban on IVF.
JAMA 2017 (PMID 28973613)
also found that in women without infertility, low AMH did not independently predict lower natural fecundity once age was accounted for.
What to do when AMH hormone is low
No vitamin reliably restores AMH enough to replace planning with a reproductive clinician.
Doable steps: (1) complete tubal and semen testing, (2) a bounded 2–3 cycle trial of ovulation induction or IUI if tubes are open, (3) pivot to IVF if unsuccessful or co-factors appear.
In many Thai clinics an “ICSI package” means a full IVF cycle; ICSI itself is a sperm-injection technique used when indicated — not a 40–50% success guarantee.
The age-36 / AMH ~0.95 ng/mL case below is a worked example, not a limit on who this article is for.
1. Decoding AMH 0.949 and antral follicle count 8–9 at age 36
An AMH of 0.949 ng/mL at age 36 is usually read as starting-to-low ovarian quantity — not sterility — and an AFC of 8–9 is not end-stage DOR under every definition.
AMH (anti-Müllerian hormone)
is produced by granulosa cells of small follicles, so it reflects quantity of remaining eggs better than it predicts “easy or hard pregnancy this month.”
Per the
ASRM 2020 committee opinion,
AMH and antral follicle count (AFC) are useful predictors of egg yield under stimulation, but poor predictors of fecundity independent of age.
Therefore AMH should not be used as a general fertility screen or as a sole reason to refuse treatment.
A value of 0.949 ng/mL is commonly read as low (many contexts use cutoffs near <1.0–1.2 ng/mL depending on the assay).
Do not assume every reproductive-age adult “should” sit at 2–4 ng/mL —
reference ranges depend on age, assay, and laboratory.
An AFC of about 8–9 is not terminal-stage low reserve under every definition (Bologna criteria for poor ovarian response often cite AFC <5–7 plus other factors).
But at age 36, per
ASRM guidance on age-related fertility decline,
egg quality and embryo aneuploidy risk tend to rise with age.
That is why clinicians talk about “racing the clock” even when follicles are still countable.
JAMA 2017
found that among women aged 30–44 without known infertility, low AMH did not meaningfully predict lower natural pregnancy rates.
Couples already in a fertility clinic live a different context — but the core message holds: low AMH ≠ sterile.
Clinical reference table: interpreting AMH (not a fixed age×normal chart)
| AMH range (example ng/mL) | Typical follicle-pool status | How it often shapes planning | What it does not tell you |
|---|---|---|---|
| Above the assay’s low band (often >1–2) | Quantity usually not labeled low | Expect more eggs per IVF cycle than low-reserve groups | Does not guarantee natural or IVF pregnancy |
| Around <1.0 (e.g., 0.949) | Fits starting-to-low reserve by quantity | Expect fewer eggs per stimulation; tighten the time plan | Not zero natural chance; assay-dependent |
| Very low (e.g., <0.5 on many assays) | Clearly reduced quantity | Higher risk of poor stimulation response; may need IVF protocol adjustments | Still not zero chance; does not replace age |
| AFC ~8–9 at age 36 | Follicles still countable; not every DOR end-stage definition | Use with AMH and age — never alone | AFC varies by operator and cycle day |
This table is not any single lab’s reference range and is not an individual diagnosis.
Optional digestive-symptom check-in
Get a personalized severity summary and guidance from our Advisory team
Take the free pelvic / gyn assessment
This tool does not diagnose infertility. Fertility planning belongs with your reproductive clinician.
2. Comparing three paths: OI+TI vs IUI vs ICSI
Low AMH still allows a time-boxed OI+TI or IUI trial if tubes are open; IVF is not barred by the AMH number, and ICSI does not raise live birth when semen is normal.
Keep the terms clear:
OI+TI is ovarian stimulation plus timed intercourse around ovulation.
IUI places prepared sperm into the uterus.
IVF is fertilization outside the body.
ICSI injects one sperm into an egg — a laboratory technique within IVF.
Per the
ASRM committee opinion on ICSI without male factor,
ICSI is not routinely recommended to raise live-birth rates when semen is normal.
Work in diminished ovarian reserve, such as
PubMed 25086790,
likewise did not show that ICSI or assisted hatching improved live birth versus conventional IVF.
So the claim “ICSI succeeds 40–50% per cycle” does not apply to every age-36 low-AMH profile.
Real ART rates depend on age, diagnosis, egg/embryo numbers, and clinic reporting rules — see
CDC ART,
which stresses that clinic statistics are not any one person’s odds.
Treatment comparison (age 35+ with lower ovarian reserve)
| Approach | Per-cycle success frame (not a personal prediction) | Advantages | Limits / time factor | Relative cost |
|---|---|---|---|---|
| OI + timed intercourse | Usually modest per cycle after age 35; no single number fits everyone | Least invasive; lower cost than ART | Few eggs per cycle; months without a stop point spend ovarian time | Much lower than IVF; depends on medication and ultrasound |
| IUI (often with ovarian stimulation) | Often single-digit to low-teens percent per cycle by age/cause — not a fixed 5–10% for every case | Helps timing and sperm quality after preparation | Both tubes generally need to be patent as assessed; average per-cycle odds below IVF | Moderate; lower than IVF |
| IVF (± ICSI when indicated) | Higher than IUI on average in many datasets, but DOR live birth per cycle is often below normal-reserve groups — not 40–50% for everyone | Can collect multiple eggs in one cycle (as ovaries allow); embryo selection in some pathways | Higher cost; injections and retrieval; ICSI does not automatically raise success when semen is normal | Much higher; varies by clinic, medication, cycles, and coverage — no currency figures here |
PGT-A is optional — not a mandatory reason for ICSI in every 36-year-old.
3. Why the time factor matters most after age 35
Age predicts egg quality more strongly than AMH, so waiting on low per-cycle methods without a 2–3 cycle stop point can mean fewer eggs when IVF starts.
Age predicts egg quality more strongly than AMH alone.
Open-ended waiting on low per-cycle methods can mean fewer eggs when IVF finally starts.
That medical logic — not a sales pitch — is why several clinicians may converge on ART.
Conversely, forcing IVF/ICSI on day one without discussing tubes, semen, budget, and mental load is not the only acceptable standard.
When tubes are open and sperm is adequate, a time-boxed OI/IUI trial is a legitimate way for many couples to get oriented — not automatically “medically wrong.”
4. A three-step grounding plan: body, budget, and mind
Use a 2–3 cycle OI/IUI frame if tubes allow, take 400–800 mcg folic acid daily before conception per CDC, then pivot to IVF and ask whether ICSI is actually indicated.
-
Set a time box, not an open runway:
If you choose OI+TI or IUI, agree in advance with your clinician to review after about 2–3 cycles (not a mandatory formula).
Avoid 6–12 months without a stop point when age is over 35 and AMH is low. -
Preconception basics:
Standard preconception
folic acid 400–800 mcg daily,
adequate sleep, and smoking cessation.
Coenzyme Q10 and vitamin D have mixed evidence — they are not treatment substitutes, and this article names no commercial brands. -
Define the IVF pivot:
If pregnancy does not occur within the agreed frame, or co-factors appear (tubal blockage, weak semen, recurrent miscarriage), discuss IVF as a treatment package.
Ask clearly whether ICSI is necessary when the semen report meets normal criteria.
This article does not order you to start or skip ICSI tomorrow.
FAQ
Can you do IVF with low AMH?
Yes. Low AMH is not a cutoff that forbids IVF. Per ASRM, AMH helps predict egg yield under stimulation but is not a sterility diagnosis and should not be used alone to deny care. What changes is eggs per cycle and the time box — not eligibility for IVF.
What should I do if my AMH hormone is low?
No vitamin reliably raises AMH enough to replace clinical planning. Complete tubal and semen testing, consider a bounded 2–3 cycle trial of ovulation induction or IUI if tubes are open, then review IVF if unsuccessful. Separate IVF from ICSI, which is a laboratory technique used when indicated.
At age 36, is an AMH of 0.949 “low egg count,” and what does it mean for pregnancy chances?
An AMH around 0.95 ng/mL is often read as below many labs’ age-typical ranges and fits diminished ovarian reserve in a quantity sense. Per ASRM, AMH/AFC help predict egg yield under stimulation but are weak predictors of natural fecundity once age is accounted for. Low AMH is not a sterility diagnosis.
If semen is normal and tubes are open, can we use ovulation induction plus timed intercourse (OI+TI)?
Technically yes when both tubes are patent and sperm meets clinical thresholds. Per-cycle odds are usually lower than ART, especially after age 35. Any trial should have a clear time box — not open-ended months without a stop point.
Why do many fertility doctors recommend ICSI immediately for women 35+ with low AMH?
The main drivers are time and eggs retrieved per cycle — not a promise that ICSI delivers 40–50% success for everyone. In many Thai clinics, “ICSI packages” label a full IVF cycle. Per ASRM, ICSI is not routinely recommended to raise live-birth rates when there is no clear male factor.
How many OI or IUI cycles before moving to ICSI without losing time?
There is no single universal number. A common counseling frame is a bounded trial of about 2–3 OI+TI or IUI cycles when tubes are open and sperm is adequate, then review IVF if unsuccessful — not 6–12 months of waiting without a plan when low reserve coincides with age over 35.
How do IVF and ICSI differ?
IVF is fertilization outside the body. ICSI is injection of one sperm into an egg — a laboratory technique used for sperm factors or prior fertilization failure. It is not a synonym for the success rate of the whole cycle.
Do I need PGT-A because I am 36?
PGT-A is an option, not a requirement for every patient over 35, and it is not by itself a reason to use ICSI. Decisions depend on embryo numbers, cost, procedure risk, and counseling with a reproductive specialist.
Can supplements raise AMH?
There is no reliable evidence that any vitamin raises AMH enough to replace time-framed planning with a fertility clinician.
Scientific mechanism (author summary)
AMH tracks the pool of small follicles (quantity), not chromosome quality of each egg — which is why a low value still allows IVF but age still sets the clock.
By Asst. Prof. Dr. Norawit Raatpiboon:
AMH reflects the pool of small, not-yet-mature follicles — a proxy for number, not per-egg quality.
Age tracks chromosomal abnormality risk in oocytes more tightly than any single hormone value.
IUI helps timing and uterine sperm selection but does not bypass tubal fertilization.
IVF moves fertilization outside the body to use that cycle’s eggs efficiently.
ICSI bypasses the zona when sperm or fertilization history is problematic — it does not repair egg chromosomes.
Support this writing
If this decision frame reduced pressure around low AMH and “must do ICSI” messaging, a coffee-sized donation keeps free, cited explainers online in Thai and English.
Citations (E-E-A-T)
Author: Asst. Prof. Dr. Norawit Raatpiboon · Discuss plans with a reproductive medicine clinician.
- ASRM 2020 — Testing and interpreting measures of ovarian reserve
- ASRM — Female age-related fertility decline
- ASRM — ICSI for nonmale-factor indications
- CDC — Assisted Reproductive Technology (ART)
- Steiner et al. JAMA 2017 — Association between biomarkers of ovarian reserve and pregnancy (PMID 28973613)
- PubMed 25086790 — ICSI and assisted hatching in diminished ovarian reserve
- MedlinePlus — Anti-Müllerian Hormone Test
- NICHD — Infertility and Fertility
- CDC — Folic acid 400–800 mcg before pregnancy
Medical disclaimer
This is general education, not a couple-specific treatment plan, and it does not guarantee pregnancy or live birth.
Educational Fertility & Reproductive Medicine content for GEO/YMYL literacy from Well Wellness Thailand / dr9ohm.com —
not an individualized infertility diagnosis or a guarantee of pregnancy or live birth.
It does not replace tubal assessment, semen analysis, ultrasound, or advice from your treating clinician.
For emergencies during stimulation, retrieval, or suspected ectopic pregnancy, go to a hospital immediately.